Asli Bolayir
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Asli Bolayir has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Burhanettin Çiğdem
Department of Neurology, School of Medicine, Sivas Cumhuriyet University, Sivas 58140, Türkiye
4 shared publications Burhanettin Cigdem
Sivas Cumhuriyet University, Medicine Faculty , Neurology Department , Sivas , Turkey
2 shared publicationsErtugrul Bolayir
2 shared publicationsHasan Ata Bolayir
Sivas Numune State Hospital , Cardiology Department , Sivas , Turkey
2 shared publications- Ozlem Kayim Yildiz
Department of Neurology, Cumhuriyet University Faculty of Medicine, Sivas, Türkiye
2 shared publications Seyda Figul Gokce
Sivas Cumhuriyet University, Medicine Faculty , Neurology Department , Sivas , Turkey
2 shared publications
Latest Publications
- Open Access
- 27 August 2026
- Published by Elsevier in eNeurologicalSci
- Vol. 45
Association of HALP score with clinical and radiological activity following fingolimod discontinuation in patients with multiple sclerosis
- 27 August 2026
- Published by Elsevier in eNeurologicalSci
- Vol. 45
Open AccessAssociation of HALP score with clinical and radiological activity following fingolimod discontinuation in patients with multiple sclerosis
- 5 April 2022
- Published by Galenos Yayinevi in Archives Of Epilepsy
- Vol. 28 (1) , 29-34
Evaluation of Monocyte/Lymphocyte, Neutrophil/Lymphocyte, and Platelet/Lymphocyte Ratios in Patients with Temporal Lobe Epilepsy
Monocyte/lymphocyte ratio,neutrophil/lymphocyte ratio,platelet/lymphocyte ratio,mesial temporal lobe epilepsy,inflammation
- 5 April 2022
- Published by Galenos Yayinevi in Archives Of Epilepsy
- Vol. 28 (1) , 29-34
Evaluation of Monocyte/Lymphocyte, Neutrophil/Lymphocyte, and Platelet/Lymphocyte Ratios in Patients with Temporal Lobe Epilepsy
Monocyte/lymphocyte ratio,neutrophil/lymphocyte ratio,platelet/lymphocyte ratio,mesial temporal lobe epilepsy,inflammation
- 1 April 2020
- Published by Pleiades Publishing Ltd in Neurochemical Journal
- Vol. 14 (2) , 243-250
The Role of Reduced Polyamine Synthesis in Ischemic Stroke
Our aim was to determine the levels of arginine decarboxylase (ADC), ornithine decarboxylase (ODC) and agmatine, ornithine, nitric oxide (NO) and arginase activity in the acute and subacute phases of acute ischemic stroke (AIS), by revealing the possible role of these levels in neuroinflammation and neurogenesis that are postulated to begin after AIS. 35 patients diagnosed with AIS and 35 controls were included in the study. ADC, ODC, agmatinase and NO levels were determined by ELISA kits. Arginase activity and ornithine levels were measured spectrophotometrically. There was no statistically significant difference between the levels of agmatinase, ornithine and arginase activity on days 1 and 7 in the AIS group and the levels measured in the control group (p > 0.05). High ADC and low ODC and NO values were found in the patients compared to the controls in both acute and subacute periods (p < 0.05). It was shown that polyamine synthesis decreased in both acute and subacute periods after AIS; and this was due to the decrease in ODC levels, the rate-regulating step of the major pathway. This reduction may be associated with both the inadequate stimulation of neurogenesis and the immune system with reduced NO synthesis. polyamine synthesis enzymes, ornithine, ornitine decarboxylase, nitric oxide, arginine decarboxylase, agmatine, agmatinase, arginase activity, neuroinflammation, neurogenesis, immune system, acute ischemic stroke.
- 1 April 2020
- Published by Pleiades Publishing Ltd in Neurochemical Journal
- Vol. 14 (2) , 243-250
The Role of Reduced Polyamine Synthesis in Ischemic Stroke
Our aim was to determine the levels of arginine decarboxylase (ADC), ornithine decarboxylase (ODC) and agmatine, ornithine, nitric oxide (NO) and arginase activity in the acute and subacute phases of acute ischemic stroke (AIS), by revealing the possible role of these levels in neuroinflammation and neurogenesis that are postulated to begin after AIS. 35 patients diagnosed with AIS and 35 controls were included in the study. ADC, ODC, agmatinase and NO levels were determined by ELISA kits. Arginase activity and ornithine levels were measured spectrophotometrically. There was no statistically significant difference between the levels of agmatinase, ornithine and arginase activity on days 1 and 7 in the AIS group and the levels measured in the control group (p > 0.05). High ADC and low ODC and NO values were found in the patients compared to the controls in both acute and subacute periods (p < 0.05). It was shown that polyamine synthesis decreased in both acute and subacute periods after AIS; and this was due to the decrease in ODC levels, the rate-regulating step of the major pathway. This reduction may be associated with both the inadequate stimulation of neurogenesis and the immune system with reduced NO synthesis. polyamine synthesis enzymes, ornithine, ornitine decarboxylase, nitric oxide, arginine decarboxylase, agmatine, agmatinase, arginase activity, neuroinflammation, neurogenesis, immune system, acute ischemic stroke.
- Open Access
- 11 February 2019
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 49 (1) , 288-294
Prevalence of multiple sclerosis in an urban population of Sivas province in Turkey
Multiple sclerosis (MS) is a common neurological disorder that can be a leading cause of nontraumatic disability in several countries. Recent reports have indicated a moderate to high risk of MS in European countries. In this study, we examined the prevalence of MS in a well-defined urban population of provincial center in Sivas Province in Turkey. This study sampled all registered residents of urban areas of provincial center in Sivas Province in April 2017 and 2018 January. All the included patients met the McDonald 2010 criteria. Medical records were reviewed, including all available previously acquired magnetic resonance imaging data. All patients were subsequently subjected to neurologic examination to confirm the MS diagnosis. We identified 21 possible MS patients, with MS diagnosis confirmed in 19. The prevalence of MS was 288 per 100,000 inhabitants. For future studies, these high ratio results can be used in regional and national comparisons to determine cofactors contributing to the high prevalence of MS in our region and can help health-decision makers to better plan healthcare policies to improve neurological services and awareness about multifaceted clinical presentations of MS.
- 11 February 2019
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 49 (1) , 288-294
Open AccessPrevalence of multiple sclerosis in an urban population of Sivas province in Turkey
Multiple sclerosis (MS) is a common neurological disorder that can be a leading cause of nontraumatic disability in several countries. Recent reports have indicated a moderate to high risk of MS in European countries. In this study, we examined the prevalence of MS in a well-defined urban population of provincial center in Sivas Province in Turkey. This study sampled all registered residents of urban areas of provincial center in Sivas Province in April 2017 and 2018 January. All the included patients met the McDonald 2010 criteria. Medical records were reviewed, including all available previously acquired magnetic resonance imaging data. All patients were subsequently subjected to neurologic examination to confirm the MS diagnosis. We identified 21 possible MS patients, with MS diagnosis confirmed in 19. The prevalence of MS was 288 per 100,000 inhabitants. For future studies, these high ratio results can be used in regional and national comparisons to determine cofactors contributing to the high prevalence of MS in our region and can help health-decision makers to better plan healthcare policies to improve neurological services and awareness about multifaceted clinical presentations of MS.
- 31 July 2018
- Published by Walter de Gruyter GmbH in Turkish Journal of Biochemistry
- Vol. 44 (1) , 16-24
Can SCUBE1 be used to predict the early diagnosis, lesion volume and prognosis of acute ischemic stroke?
Objective: SCUBE1 [signal peptide-CUB (complement C1r/C1 s)-EGF (epidermal growth factor)-like domain-containing protein 1] is a novel biochemical marker. SCUBE1 is thought to play roles both in platelet activation and inflammation, which are important stages for the development of acute ischemic stroke (AIS).The purpose of our study was to determine the diagnostic and prognostic values and temporal change of plasma SCUBE1 levels in AIS patients. Materials and methods: Thirty-five patients diagnosed with AIS at the Cumhuriyet University Faculty of Medicine Neurology Department, between June and December 2017, and a control group of 35 healthy volunteers were included. Results: Median first day SCUBE1 value in the patient group was 97.51 ng/mL, and the median 7th day SCUBE1 value was 32.72 ng/mL. Median control group SCUBE1 value was 27.51 ng/mL. The first day SCUBE1 levels were significantly higher than the 7th day and the control group SCUBE1 levels (p=0.001, p<0.001, respectively). The ROC analysis showed that SCUBE1 levels above 68.8 ng/mL can be used as an indicator with high sensitivity and specificity for AIS diagnosis. Multivariate analysis revealed that the first day SCUBE1 had significant independent effects on development of AIS. In correlation analysis, plasma SCUBE1 levels showed a significantly positive correlation with lesion volume, NIHSS and MRS values (p<0.01). Conclusion: First day plasma SCUBE1 values in AIS patients rised at significant levels compared to the control group. SCUBE1 could use both in the early diagnosis and prediction of prognosis and lesion volume of AIS patients.
- 31 July 2018
- Published by Walter de Gruyter GmbH in Turkish Journal of Biochemistry
- Vol. 44 (1) , 16-24
Can SCUBE1 be used to predict the early diagnosis, lesion volume and prognosis of acute ischemic stroke?
Objective: SCUBE1 [signal peptide-CUB (complement C1r/C1 s)-EGF (epidermal growth factor)-like domain-containing protein 1] is a novel biochemical marker. SCUBE1 is thought to play roles both in platelet activation and inflammation, which are important stages for the development of acute ischemic stroke (AIS).The purpose of our study was to determine the diagnostic and prognostic values and temporal change of plasma SCUBE1 levels in AIS patients. Materials and methods: Thirty-five patients diagnosed with AIS at the Cumhuriyet University Faculty of Medicine Neurology Department, between June and December 2017, and a control group of 35 healthy volunteers were included. Results: Median first day SCUBE1 value in the patient group was 97.51 ng/mL, and the median 7th day SCUBE1 value was 32.72 ng/mL. Median control group SCUBE1 value was 27.51 ng/mL. The first day SCUBE1 levels were significantly higher than the 7th day and the control group SCUBE1 levels (p=0.001, p<0.001, respectively). The ROC analysis showed that SCUBE1 levels above 68.8 ng/mL can be used as an indicator with high sensitivity and specificity for AIS diagnosis. Multivariate analysis revealed that the first day SCUBE1 had significant independent effects on development of AIS. In correlation analysis, plasma SCUBE1 levels showed a significantly positive correlation with lesion volume, NIHSS and MRS values (p<0.01). Conclusion: First day plasma SCUBE1 values in AIS patients rised at significant levels compared to the control group. SCUBE1 could use both in the early diagnosis and prediction of prognosis and lesion volume of AIS patients.
- Open Access
- 5 June 2018
- Published by Cumhuriyet Medical Journal in Cumhuriyet Medical Journal
- Vol. 40 (2) , 120-127
Can lymphocyte to monocyte ratio be used as a predictor of atherosclerotic carotid plaques in elderly adults?
- 5 June 2018
- Published by Cumhuriyet Medical Journal in Cumhuriyet Medical Journal
- Vol. 40 (2) , 120-127
Open AccessCan lymphocyte to monocyte ratio be used as a predictor of atherosclerotic carotid plaques in elderly adults?
- Open Access
- 1 May 2018
- Published by Elsevier in Revista Portuguesa de Cardiologia
- Vol. 37 (5) , 375-381
The role of SCUBE1 in the development of late stent thrombosis presenting with ST-elevation myocardial infarction
- 1 May 2018
- Published by Elsevier in Revista Portuguesa de Cardiologia
- Vol. 37 (5) , 375-381
Open AccessThe role of SCUBE1 in the development of late stent thrombosis presenting with ST-elevation myocardial infarction
- 1 March 2018
- Published by VM Media Group sp. z o.o in Neurologia i Neurochirurgia Polska
- Vol. 52 (2) , 150-155
Monocyte/high-density lipoprotein ratio predicts the mortality in ischemic stroke patients
The inflammatory process is a very important stage in the development and prognosis of acute ischemic stroke (AIS). The monocyte to high-density lipoprotein (HDL) ratio (MHR) is accepted as a novel marker for demonstrating inflammation. However, the role of MHR as a predictor of mortality in patients with AIS remains unclear. We retrospectively enrolled 466 patients who were referred to our clinic within the first 24hours of symptom presentation and who were diagnosed with AIS between January 2008 and June 2016. Four hundred and eight controls of similar age and gender were also included. The patient group was classified into two groups according to 30-day mortality. The groups were compared in terms of monocyte counts, HDL, and MHR values. The patient group had significantly higher monocyte counts and lower HDL levels; therefore, this group had higher values of MHR compared to controls. Additionally, the monocyte count and MHR value were higher, and the HDL level was lower in non-surviving patients (p<0.001). The MHR value was also observed as a significant independent variable of 30-day mortality in patients with AIS (p<0.001). The optimum cut-off value of MHR in predicting the 30-day mortality for patients with AIS was 17.52 (95% CI 0.95-0.98). Our study demonstrated that a high MHR value is an independent predictor of 30-day mortality in patients with AIS.
- 1 March 2018
- Published by VM Media Group sp. z o.o in Neurologia i Neurochirurgia Polska
- Vol. 52 (2) , 150-155
Monocyte/high-density lipoprotein ratio predicts the mortality in ischemic stroke patients
The inflammatory process is a very important stage in the development and prognosis of acute ischemic stroke (AIS). The monocyte to high-density lipoprotein (HDL) ratio (MHR) is accepted as a novel marker for demonstrating inflammation. However, the role of MHR as a predictor of mortality in patients with AIS remains unclear. We retrospectively enrolled 466 patients who were referred to our clinic within the first 24hours of symptom presentation and who were diagnosed with AIS between January 2008 and June 2016. Four hundred and eight controls of similar age and gender were also included. The patient group was classified into two groups according to 30-day mortality. The groups were compared in terms of monocyte counts, HDL, and MHR values. The patient group had significantly higher monocyte counts and lower HDL levels; therefore, this group had higher values of MHR compared to controls. Additionally, the monocyte count and MHR value were higher, and the HDL level was lower in non-surviving patients (p<0.001). The MHR value was also observed as a significant independent variable of 30-day mortality in patients with AIS (p<0.001). The optimum cut-off value of MHR in predicting the 30-day mortality for patients with AIS was 17.52 (95% CI 0.95-0.98). Our study demonstrated that a high MHR value is an independent predictor of 30-day mortality in patients with AIS.
- 18 December 2017
- Published by Cumhuriyet Medical Journal in Cumhuriyet Medical Journal
- Vol. 39 (4) , 683-691
The role of mean platelet volume, platelet distribution width and platelet / lymphocyte ratio in development of cerebral venous thrombosis
Amaç: Ortalama platelet hacmi (OPH) ve platelet dağılım genişliği (PDG), platelet hacmini gösteren parametrelerdir. Büyük plateletlerin küçük plateletlere kıyasla enzimatik ve metabolik olarak daha aktif kabul edilmektedir. Artmış OPH ve PDG değerleri ile arteryel tromboz arasındaki ilişki gösterilmiştir ancak venöz trombozdaki yeri tam olarak bilinmemektedir. İnflamatuar bir gösterge kabul edilen platelet/ lenfosit oranının artışının(PLO) birçok hastalıkla ilişkisi bilinmekteyken venöz trombozda kullanımı ile ilgili az sayıda çalışma mevcuttur. Bu nedenle bu çalışmamızdaki amacımız OPH, PDG ve PLO değerleri ile serebral venöz sinüs trombozu(SVST) arasındaki ilişkiyi ortaya koymaktır. Yöntem: Çalışmamıza retrospektif olarak Ocak 2008- Eylül 2016 tarihleri arasında kliniğimizde SVST tanısı ile izlenmiş 54 hasta ile benzer yaş ve cinsiyete sahip 50 kontrol dahil edildi. Hasta ve kontrol grubu OPH, PDG ve PLO değerleri açısından kıyaslandı. Bunun yanında hasta grubu kendi içinde beyin parankimal lezyonu olan ve olmayanlar olarak ikiye ayrılarak OPH, PDG ve PLO’nun prognoz üzerindeki etkisi de değerlendirildi. Bulgular: Hasta grubunda kontrollere kıyasla OPH, PDG ve PLO değerleri daha yüksekken parankimal lezyonu olan ve olmayan hastalar arasında anlamlı fark saptanmadı. Ek olarak SVST gelişimi için OPH ve PDG değerleri anlamlı bağımsız değişkenler olarak saptanırken ROC analizi ile optimum cut-off değerleri OPH için 8.85 iken, PDG için 15.75, PLO için ise 168.53 olarak tespit edildi. Sonuç: Sonuç olarak, OPH, PDG ve PLO değerleri SVST’li hastalarda kontrollerden daha yüksek bulunmuştur ancak prognozu belirlemede etkileri saptanmamıştır. Ek olarak, OPH ile PDG yüksekliğinin SVST gelişimi için yeni bir bağımsız risk faktörleri olduğunu söyleyebiliriz.
- 18 December 2017
- Published by Cumhuriyet Medical Journal in Cumhuriyet Medical Journal
- Vol. 39 (4) , 683-691
The role of mean platelet volume, platelet distribution width and platelet / lymphocyte ratio in development of cerebral venous thrombosis
Amaç: Ortalama platelet hacmi (OPH) ve platelet dağılım genişliği (PDG), platelet hacmini gösteren parametrelerdir. Büyük plateletlerin küçük plateletlere kıyasla enzimatik ve metabolik olarak daha aktif kabul edilmektedir. Artmış OPH ve PDG değerleri ile arteryel tromboz arasındaki ilişki gösterilmiştir ancak venöz trombozdaki yeri tam olarak bilinmemektedir. İnflamatuar bir gösterge kabul edilen platelet/ lenfosit oranının artışının(PLO) birçok hastalıkla ilişkisi bilinmekteyken venöz trombozda kullanımı ile ilgili az sayıda çalışma mevcuttur. Bu nedenle bu çalışmamızdaki amacımız OPH, PDG ve PLO değerleri ile serebral venöz sinüs trombozu(SVST) arasındaki ilişkiyi ortaya koymaktır. Yöntem: Çalışmamıza retrospektif olarak Ocak 2008- Eylül 2016 tarihleri arasında kliniğimizde SVST tanısı ile izlenmiş 54 hasta ile benzer yaş ve cinsiyete sahip 50 kontrol dahil edildi. Hasta ve kontrol grubu OPH, PDG ve PLO değerleri açısından kıyaslandı. Bunun yanında hasta grubu kendi içinde beyin parankimal lezyonu olan ve olmayanlar olarak ikiye ayrılarak OPH, PDG ve PLO’nun prognoz üzerindeki etkisi de değerlendirildi. Bulgular: Hasta grubunda kontrollere kıyasla OPH, PDG ve PLO değerleri daha yüksekken parankimal lezyonu olan ve olmayan hastalar arasında anlamlı fark saptanmadı. Ek olarak SVST gelişimi için OPH ve PDG değerleri anlamlı bağımsız değişkenler olarak saptanırken ROC analizi ile optimum cut-off değerleri OPH için 8.85 iken, PDG için 15.75, PLO için ise 168.53 olarak tespit edildi. Sonuç: Sonuç olarak, OPH, PDG ve PLO değerleri SVST’li hastalarda kontrollerden daha yüksek bulunmuştur ancak prognozu belirlemede etkileri saptanmamıştır. Ek olarak, OPH ile PDG yüksekliğinin SVST gelişimi için yeni bir bağımsız risk faktörleri olduğunu söyleyebiliriz.
- 1 October 2017
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 26 (10) , 2248-2255
The Effect of Eosinopenia on Mortality in Patients with Intracerebral Hemorrhage
- 1 October 2017
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 26 (10) , 2248-2255
The Effect of Eosinopenia on Mortality in Patients with Intracerebral Hemorrhage